[go: up one dir, main page]

UA83988C2 - Monoclonal andidual integrine antibody, specifically binding human integrines alpha v beta 3 and alpha v beta 5, pharmaceutical composition, containing it, and its use in therapy - Google Patents

Monoclonal andidual integrine antibody, specifically binding human integrines alpha v beta 3 and alpha v beta 5, pharmaceutical composition, containing it, and its use in therapy

Info

Publication number
UA83988C2
UA83988C2 UA2003021153A UA2003021153A UA83988C2 UA 83988 C2 UA83988 C2 UA 83988C2 UA 2003021153 A UA2003021153 A UA 2003021153A UA 2003021153 A UA2003021153 A UA 2003021153A UA 83988 C2 UA83988 C2 UA 83988C2
Authority
UA
Ukraine
Prior art keywords
beta
alpha
integrines
therapy
pharmaceutical composition
Prior art date
Application number
UA2003021153A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джил Гилес-Комар
Линда Снайдер
Мохит Трикха
Original Assignee
Центокор, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центокор, Инк. filed Critical Центокор, Инк.
Priority claimed from PCT/US2001/024784 external-priority patent/WO2002012501A2/en
Publication of UA83988C2 publication Critical patent/UA83988C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to the monoclonal human antibody, specifically binding the human integrines Alpha V Beta 3 (αβ) and Alpha V Beta 5 (αβ), pharmaceutical composition, containing it, and theirs application in therapy, at the production of medicaments for the treatment or prevention of diseases, mediated by integrines αβand αβ, in particular for the treatment of cancerous diseases.
UA2003021153A 2000-08-07 2001-08-07 Monoclonal andidual integrine antibody, specifically binding human integrines alpha v beta 3 and alpha v beta 5, pharmaceutical composition, containing it, and its use in therapy UA83988C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22336300P 2000-08-07 2000-08-07
US92026701P 2001-08-01 2001-08-01
PCT/US2001/024784 WO2002012501A2 (en) 2000-08-07 2001-08-07 Anti-dual integrin antibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
UA83988C2 true UA83988C2 (en) 2008-09-10

Family

ID=50724194

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2003021153A UA83988C2 (en) 2000-08-07 2001-08-07 Monoclonal andidual integrine antibody, specifically binding human integrines alpha v beta 3 and alpha v beta 5, pharmaceutical composition, containing it, and its use in therapy

Country Status (3)

Country Link
CY (1) CY1110755T1 (en)
MY (1) MY155265A (en)
UA (1) UA83988C2 (en)

Also Published As

Publication number Publication date
MY155265A (en) 2015-09-30
CY1110755T1 (en) 2015-06-10

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
DE60028970D1 (en) AT HER2 BINDING PEPTIDE COMPOUNDS
BG110703A (en) Pharmaceutical composition comprising human antibodies that bind human tnf-alpha and application of this composition
YU37602A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
AU4550801A (en) Herbal composition phy906 and its use in chemotheraphy
BG66083B1 (en) Pharmaceutical compositions containing antibodies, and antibodies for prevention andf treatment of amyloidogenic disease
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
EP0797999A3 (en) Formulations of obesity protein
GR3035762T3 (en) Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
PL369148A1 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
TR200100637T2 (en) New natural product derivatives
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
EE200100689A (en) Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition
WO2002066492A3 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
UA83988C2 (en) Monoclonal andidual integrine antibody, specifically binding human integrines alpha v beta 3 and alpha v beta 5, pharmaceutical composition, containing it, and its use in therapy
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ECSP993206A (en) METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR
WO2002102849A3 (en) Bcmp-101, a cancer associated protein
HU0105291D0 (en) Pharmaceutical compositions for the treatment of indigestion and related diseases
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors